Breaking News
Subscribe Now 0
🎈 Up Big Today: Find today's biggest gainers (some over 50%!) with our free screener
Try Stock Screener
Close

Manulife Srp Growth Portfolio (0P0000XQG3)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.820 -0.020    -1.10%
01/11 - Delayed Data. Currency in USD
  • Morningstar Rating:
  • Total Assets: 15.32M
Type:  Fund
Market:  Singapore
Issuer:  Manulife (Singapore) Pte Ltd
Asset Class:  Equity
Manulife SRP Growth Portfolio 1.820 -0.020 -1.10%

0P0000XQG3 Holdings

 
Comprehensive information about top holdings and Key Holding Information for the Manulife SRP Growth Portfolio (0P0000XQG3) fund. Our Manulife SRP Growth Portfolio portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 2.010 2.010 0.000
Stocks 59.210 59.210 0.000
Bonds 33.420 33.420 0.000
Convertible 0.730 0.730 0.000
Preferred 4.260 4.260 0.000
Other 0.370 0.370 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 19.335 17.278
Price to Book 2.692 2.695
Price to Sales 2.427 1.953
Price to Cash Flow 11.547 11.157
Dividend Yield 2.202 2.555
5 Years Earnings Growth 11.106 11.472

Sector Allocation

Name  Net % Category Average
Technology 23.010 20.277
Consumer Cyclical 14.810 9.755
Real Estate 13.550 6.990
Financial Services 13.390 16.362
Healthcare 9.390 12.137
Communication Services 8.730 6.705
Industrials 5.540 10.900
Consumer Defensive 5.530 7.429
Energy 4.390 4.518
Basic Materials 1.110 3.898
Utilities 0.560 3.530

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Australasia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 7

Number of short holdings: 0

Name ISIN Weight % Last Change %
Manulife GF US Eq AA Shrs LU0314104364 41.44 - -
  Manulife Global Fund - U.S. Bond Fund AA LU0278409817 23.14 1.018 +0.23%
Manulife GF US Special Opps AA LU0278410153 16.09 - -
  Manulife Global Fund European Growth Fund AA LU0314106062 8.20 1.019 +1.51%
  Manulife Global Fund Global Property Fund AA LU0278409221 6.97 1.047 -0.07%
Manulife GF Japan Eq AA Shrs LU0314107540 3.09 - -
  Manulife Global Fund Asian Equity Fund AA LU0314105171 1.07 1.425 +0.94%

Top Equity Funds by Manulife (Singapore) Pte Ltd

  Name Rating Total Assets YTD% 3Y% 10Y%
  Manulife SRP Aggressive Portfolio 30.09M 12.17 2.25 5.67
  Manulife SRP Balanced Portfolio 5.12M 8.11 -0.40 2.67
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000XQG3 Comments

Write your thoughts about Manulife Srp Growth Portfolio
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email